James Molloy
Stock Analyst at Alliance Global Partners
(0.52)
# 3,645
Out of 4,670 analysts
30
Total ratings
29.41%
Success rate
-19.88%
Average return
Main Sectors:
Stocks Rated by James Molloy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GOVX GeoVax Labs | Initiates: Buy | $15 | $2.70 | +455.56% | 1 | Nov 11, 2024 | |
| INMB INmune Bio | Initiates: Buy | $20 | $4.76 | +320.17% | 1 | Oct 21, 2024 | |
| SCLX Scilex Holding Company | Initiates: Buy | $14 | $0.55 | +2,438.53% | 1 | Oct 16, 2024 | |
| TNXP Tonix Pharmaceuticals Holding | Maintains: Buy | $6 → $11 | $0.20 | +5,286.88% | 7 | Jul 22, 2024 | |
| PED PEDEVCO | Initiates: Buy | $1.75 | $0.89 | +96.65% | 1 | Jul 17, 2024 | |
| PXS Pyxis Tankers | Initiates: Buy | $10 | $4.02 | +148.76% | 1 | Jul 17, 2024 | |
| IGC IGC Pharma | Initiates: Buy | $3.5 | $0.35 | +892.91% | 1 | Jul 17, 2024 | |
| CHRO Chromocell Therapeutics | Initiates: Buy | n/a | $0.63 | - | 1 | Jun 18, 2024 | |
| XRTX XORTX Therapeutics | Maintains: Buy | $9 → $14 | $1.27 | +1,006.72% | 2 | Jan 4, 2024 | |
| SYBX Synlogic | Initiates: Buy | $30 | $1.41 | +2,035.23% | 1 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7.5 | $0.92 | +715.22% | 1 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $5.79 | +245.42% | 1 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $1.22 | +555.74% | 1 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $7 | $4.51 | +55.21% | 2 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $1.24 | +6,351.61% | 1 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $1.24 | +1,190.32% | 1 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $1.30 | +976.92% | 1 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $0.69 | +2,064.50% | 1 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $240 | $0.62 | +38,609.68% | 1 | Sep 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $150 | $2.85 | +5,163.16% | 1 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $63 | $0.34 | +18,451.50% | 1 | Jun 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $4.33 | +477.37% | 1 | Oct 4, 2021 |
GeoVax Labs
Nov 11, 2024
Initiates: Buy
Price Target: $15
Current: $2.70
Upside: +455.56%
INmune Bio
Oct 21, 2024
Initiates: Buy
Price Target: $20
Current: $4.76
Upside: +320.17%
Scilex Holding Company
Oct 16, 2024
Initiates: Buy
Price Target: $14
Current: $0.55
Upside: +2,438.53%
Tonix Pharmaceuticals Holding
Jul 22, 2024
Maintains: Buy
Price Target: $6 → $11
Current: $0.20
Upside: +5,286.88%
PEDEVCO
Jul 17, 2024
Initiates: Buy
Price Target: $1.75
Current: $0.89
Upside: +96.65%
Pyxis Tankers
Jul 17, 2024
Initiates: Buy
Price Target: $10
Current: $4.02
Upside: +148.76%
IGC Pharma
Jul 17, 2024
Initiates: Buy
Price Target: $3.5
Current: $0.35
Upside: +892.91%
Chromocell Therapeutics
Jun 18, 2024
Initiates: Buy
Price Target: n/a
Current: $0.63
Upside: -
XORTX Therapeutics
Jan 4, 2024
Maintains: Buy
Price Target: $9 → $14
Current: $1.27
Upside: +1,006.72%
Synlogic
Dec 11, 2023
Initiates: Buy
Price Target: $30
Current: $1.41
Upside: +2,035.23%
Jul 17, 2023
Initiates: Buy
Price Target: $7.5
Current: $0.92
Upside: +715.22%
May 24, 2023
Reiterates: Buy
Price Target: $20
Current: $5.79
Upside: +245.42%
Nov 15, 2022
Maintains: Buy
Price Target: $14 → $8
Current: $1.22
Upside: +555.74%
Nov 4, 2022
Maintains: Buy
Price Target: $10 → $7
Current: $4.51
Upside: +55.21%
Nov 1, 2022
Initiates: Buy
Price Target: $80
Current: $1.24
Upside: +6,351.61%
Nov 1, 2022
Initiates: Buy
Price Target: $16
Current: $1.24
Upside: +1,190.32%
Oct 20, 2022
Initiates: Buy
Price Target: $14
Current: $1.30
Upside: +976.92%
Oct 13, 2022
Initiates: Buy
Price Target: $15
Current: $0.69
Upside: +2,064.50%
Sep 7, 2022
Initiates: Buy
Price Target: $240
Current: $0.62
Upside: +38,609.68%
Aug 25, 2022
Initiates: Buy
Price Target: $150
Current: $2.85
Upside: +5,163.16%
Jun 1, 2022
Initiates: Buy
Price Target: $63
Current: $0.34
Upside: +18,451.50%
Oct 4, 2021
Initiates: Buy
Price Target: $25
Current: $4.33
Upside: +477.37%